Arterosil, a patent-pending nutraceutical, is the only product in the world that has been clinically proven to rebuild the endothelial glycocalyx. Arterosil contains specialized sulfated polysaccharides (SSP) derived from a rare seaweed. Certain SSP rich seaweeds are glycocalyx regenerating compounds (GRC) and have been reported to possess anticoagulant and antithrombotic activity13.
The SSP in Arterosil has a similar chemical structure to heparan sulfate found abundantly in human endothelial glycocalyx and may exert its biological activities by regenerating endothelial glycocalyx.
Arterosil is available exclusively through licensed health care practitioners. Manufactured in the USA, Arterosil currently ships to the 50 United States and Puerto Rico only.
U.S. and International Patents Pending (covers pharmaceutical and nutraceutical embodiments)